EN | UA
EN | UA

Help Support

Back

Efficacy evaluation of clonazepam for symptom remission in burning mouth syndrome: a meta-analysis

Efficacy evaluation of clonazepam for symptom remission in burning mouth syndrome: a meta-analysis Efficacy evaluation of clonazepam for symptom remission in burning mouth syndrome: a meta-analysis
Efficacy evaluation of clonazepam for symptom remission in burning mouth syndrome: a meta-analysis Efficacy evaluation of clonazepam for symptom remission in burning mouth syndrome: a meta-analysis

Clonazepam has been used in the treatment of burning mouth syndrome (BMS) for several decades. 

See All

Key take away

Clonazepam is used to treat pain disorders and seizures. Oral pain sensations can be effectively treated using clonazepam according to the literature studies and the statistical analysis of the results obtained from this present study.

Background

Clonazepam has been used in the treatment of burning mouth syndrome (BMS) for several decades. We conducted a meta-analysis to investigate the efficacy of clonazepam in the treatment of BMS.

Method

We conducted a search of the PubMed, MEDLINE, EMBASE, Web of Science (TS), and the Cochrane Library databases for relevant studies that met our eligibility criteria (up to September 22, 2015). Statistical analyses were conducted using RevMan 5.2 and STATA 11.0 software.

Result

Three randomized controlled trials (RCTs) and two high-quality case–control studies involving 195 BMS patients were selected for this study. Our results show that clonazepam can reduce the oral pain sensation in patients with BMS (WMD: −3.72, 95% CI: −4.57, −2.86; P < 0.05; for all five studies). A positive therapeutic effect was demonstrated for both short-term (≤10 weeks) application (WMD: −1.44, 95% CI: −2.06, −0.82; P < 0.05) and long-term (>10 weeks) application (WMD: −4.50, 95% CI: −4.98, −4.03; P < 0.05). Both topical (WMD: −1.50, 95% CI: −2.14, −0.85; P < 0.05) and systemic (WMD: −3.81, 95% CI: −4.63, −2.98; P < 0.05) administration of clonazepam were confirmed to be effective.

Conclusion

Clonazepam is effective in inducing symptom remission in patients with BMS.

Source:

Oral Dis. 2015 Dec 17

Article:

Efficacy evaluation of clonazepam for symptom remission in burning mouth syndrome: a meta-analysis

Authors:

Y Cui et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: